Daniel M. Bendheim, Executive VP, Corporate Strategy at PHIBRO ANIMAL HEALTH CORP (PAHC), sold 7,500 shares at $31.40 ($237K) on 2019-01-22, disclosed to the SEC on 2019-01-24.
Open-market sale of $237k PAHC by Executive VP, Corporate Strategy. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.40 | 2,500 | $79K | 33.1% |
| 2 | $31.58 | 1,910 | $60K | 25.4% |
| 3 | $32.18 | 590 | $19K | 8.0% |
| 4 | $31.78 | 2,500 | $79K | 33.5% |
| Total | $31.63 avg | 7,500 | $237K | 100% |
| Filing → |
| PAHC | SELL | 2019-01-10 | $162K | — | Filing → |
| PAHC | SELL | 2019-01-07 | $238K | — | Filing → |
| PAHC | SELL | 2018-09-14 | $111K | — | Filing → |